抗凝剂:基于证据的医学,并不总是道德的
Francesco Marongiu1,2, Antonella Mameli3, Silvia Marongiu3
1Department of Internal Medicine, University of Cagliari, Cagliari, Italy.
Seminars in thrombosis and hemostasis
|October 23, 2025
概括
基于证据的医学 (EBM) 对静脉血栓栓塞 (VTE) 和心房 (AF) 的抗凝剂的试验有时缺乏伦理考虑. 在随机临床试验 (RCT) 中,安慰剂对照和非劣势边缘可能造成伤害.
科学领域:
- 医学伦理 医学伦理
- 临床试验方法论 临床试验方法论
- 基于证据的医学基于证据的医学.
背景情况:
- 基于证据的医学 (EBM) 传播科学方法,但也面临着道德挑战.
- 早期的EBM在管理静脉血栓塞栓症 (VTE) 和心房动 (AF) 中缺乏道德考虑.
- 在抗凝固剂开发中,EBM和伦理原则的融合需要进行批判性审查.
研究的目的:
- 批判性地审查EBM在VTE和AF中使用抗凝剂的伦理考虑.
- 分析试验中的方法严谨性是否掩盖了临床伦理学.
- 探索安慰剂对照试验的合理性和伦理影响以及非劣势边际.
主要方法:
- 关键随机临床试验 (RCT) 的批判性审查,用于VTE和AF的抗凝固剂治疗和预防.
- 对使用安慰剂对照与观察数据的伦理理由的分析.
- 在抗凝药试验中评估非劣势差额方法.
主要成果:
- 几项使用安慰剂对抗抗凝血剂对照的RCT在伦理上是可疑的,鉴于观察性研究的现有证据.
- 在某些试验中使用安慰剂导致不合理的死亡率和发病率.
- 非劣势差额方法可能过于慷慨,可能导致"生物危险"现象.
结论:
- 过度依赖RCT,有时使用有缺陷的方法 (例如,不道德的安慰剂),可能会不利于患者的护理.
- 在EBM的方法严格必须与伦理原则平衡,特别是在抗凝药研究.
- 重新评估试验设计和伦理监督对于推进患者护理和临床研究至关重要.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
01:29Venous Thrombosis III: Interprofessional Care
278
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
278
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:30Venous Thrombosis IV: Nursing Management
192
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
192
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
311
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
311